Published 21 April 2020 The West Sweden Asthma Study (WSAS) is a population-representative longitudinal study established to: generate data on prevalence trends, incidence and remission of asthma, allergy and respiratory conditions, elucidate on the risk and prognostic factors associated with these diseases, characterise clinically relevant phenotypes of these diseases and catalyse relevant mechan

https://www.lupop.lu.se/article/cohort-profile-west-sweden-asthma-study-wsas-multidisciplinary-population-based-longitudinal-study - 2025-07-09

Published 22 April 2020 Treatment options for peritoneal metastases (PM) from colorectal cancer (CRC) have increased, their efficiency should be monitored. For this purpose, register-based data on PM can be used, if valid. Purpose: We aimed to evaluate the completeness and positive predictive value (PPV) of synchronous peritoneal metastases (S-PM) registered among CRC patients in the Danish Nation

https://www.lupop.lu.se/article/validity-registered-synchronous-peritoneal-metastases-colorectal-cancer-danish-medical-registries - 2025-07-09

Published 23 April 2020 Carotid-femoral pulse wave velocity (cfPWV) and its risk factors may differ between various populations. Few studies have compared the risk profiles associated with cfPWV in different ethnic populations. The study population included 4321 subjects from Shanghai, China (n = 1272, age 75.0 ± 6.5 years, female 57.3%) and Malmö, Sweden (n = 3049, age 72.5 ± 5.5 years, female 60

https://www.lupop.lu.se/article/difference-risk-profiles-carotid-femoral-pulse-wave-velocity-results-two-community-based-studies - 2025-07-09

Published 24 April 2020 The Systemic Anti-Cancer Therapy (SACT) database is a population-based resource of SACT activity reported routinely by National Health Service (NHS) trusts in England. Data are collected on the SACT treatments of adult and paediatric patients, delivered in secondary and tertiary settings with the intention of improving survival, delaying further cancer progression or develo

https://www.lupop.lu.se/article/data-resource-profile-systemic-anti-cancer-therapy-sact-dataset - 2025-07-09

Published 16 April 2020 Statusrapport i Vetenskapsrådets uppdrag – summering av arbetet 2017–2019 och fortsatt arbete Läs mer här.

https://www.lupop.lu.se/article/samordning-av-oppen-tillgang-till-forskningsdata - 2025-07-09

Published 25 April 2020 There are limited data regarding efficacy of abatacept treatment for rheumatoid arthritis (RA) outside clinical trials. Quality registers have been useful for observational studies on tumor necrosis factor inhibition in clinical practice. The aim of this study was to investigate clinical efficacy and tolerability of abatacept in RA, using a national register. New publicatio

https://www.lupop.lu.se/article/abatacept-rheumatoid-arthritis-survival-drug-clinical-outcomes-and-their-predictors-data-large - 2025-07-09

Published 26 April 2020 The National Cancer Registration and Analysis Service (NCRAS), part of Public Health England (PHE), is the population-based cancer registry for England. It collects, quality assures and analyses data on all people living in England who are diagnosed with malignant and pre-malignant neoplasms, with national coverage since 1971. It produces the national cancer registration da

https://www.lupop.lu.se/article/data-resource-profile-national-cancer-registration-dataset-england - 2025-07-09

Published 30 January 2018 Lecturer: Tyler J. VanderWeele, Ph.D., Professor of Epidemiology in the Departments of Epidemiology and Biostatistics at the Harvard T.H. Chan School of Public, Boston, MA, USA Find more information here.

https://www.lupop.lu.se/article/workshop-causal-mediation-and-interaction-analysis - 2025-07-09

Published 27 April 2020 A circumferential resection margin (CRM) of 1·0 mm or less after rectal cancer surgery is thought to increase the risk of local recurrence (LR). This retrospective population‐based study examined how CRM distance affects the LR risk. New publication in BJS Society

https://www.lupop.lu.se/article/risk-local-recurrence-rectal-cancer-and-circumferential-resection-margin-population-based-cohort - 2025-07-09

Published 28 April 2020 The National Cancer Institute’s (NCI) Health Information National Trends Survey (HINTS) was conceived in 1997 during a multidisciplinary conference focused on risk communication with attenders representing the fields of psychology, health behaviour and education, public health, clinical medicine and health journalism. The key recommendation born of this conference encourage

https://www.lupop.lu.se/article/data-resource-profile-national-cancer-institutes-health-information-national-trends-survey-hints - 2025-07-09

Published 24 April 2020 Evolution, projections and impact of government measures (European Journal of Epidemiology) Read more here.

https://www.lupop.lu.se/article/covid-19-epidemic-italy - 2025-07-09

Published 25 April 2020 Genom ett gemensamt initiativ från Arbets-och miljömedicin i Stockholm, Göteborg och Lund har en tvärprofessionell arbetsgrupp bildats för att utifrån Folkhälsomyndighetens och Världshälsoorganisationens (WHO) riktlinjer ta fram anpassade hälsoråd till personer och familjer med boende i förorter och andra områden med stora förutsättningar för smittspridning. Läs mer på http

https://www.lupop.lu.se/article/covid-19-i-trangbodda-fororter - 2025-07-09

Published 26 April 2020 Med anledning av Covid-19 och den rådande utvecklingen i Sverige och världen har Formas forskarråd beslutat att omgående öppna akututlysningen 2020. Formas vill inom rådets ansvarsområden, ge möjligheten att samla in data/forskningsmaterial av akut karaktär för att säkerställa framtida tillgänglighet för forskning. Läs mer på https://www.formas.se/arkiv/alla-utlysningar/utl

https://www.lupop.lu.se/article/formas-akututlysning-2020 - 2025-07-09

Published 29 April 2020 Epidemiologists are often confronted with datasets to analyse which contain measurement error due to, for instance, mistaken data entries, inaccurate recordings and measurement instrument or procedural errors. If the effect of measurement error is misjudged, the data analyses are hampered and the validity of the study’s inferences may be affected. In this paper, we describe

https://www.lupop.lu.se/article/reflection-modern-methods-five-myths-about-measurement-error-epidemiological-research - 2025-07-09

Published 1 February 2018 Updated FAQ regarding personal data on LU's project blog Påverkar dataskyddsförordningen hur vi behandlar gamla personuppgifterNär och hur bör vi använda samtycke som rättslig grund för behandling av personuppgifterVad gäller för gamla samtycken?Svaren hittar du på: https://personuppgifter.blogg.lu.se/faq/============Does the General Data Protection Regulation affect how

https://www.lupop.lu.se/article/about-consent-and-old-data - 2025-07-09

Published 30 April 2020 Treatment of postoperative pain remains a significant clinical problem, and prediction of patients with a risk of higher postoperative pain levels is an important focus. We aimed to identify patients undergoing total hip arthroplasty (THA) with risk of higher pain levels at 24 h postoperatively by using four simple and easily available clinical tools. New publication in BMC

https://www.lupop.lu.se/article/using-four-different-clinical-tools-predictors-pain-after-total-hip-arthroplasty-prospective-cohort - 2025-07-09

By lina [dot] tornquist [at] innovation [dot] lu [dot] se (Lina Törnquist) - published 17 June 2025 With SEK 36 million in funding, stakeholders in Skåne are joining forces to develop and commercialise breakthrough ATMP research – Advanced Therapy Medical Products. The aim is to accelerate the next generation of these therapies so that more potentially life-saving ATMP treatments reach patients wh

https://www.innovation.lu.se/en/article/major-investment-accelerates-advanced-therapies-research-patient - 2025-07-09

Published 18 June 2025 Lao Saal and Anthony George, founders of SAGA Diagnostics SAGA Diagnostics, a portfolio company of LU Ventures, has the potential to transform cancer care by detecting cancer recurrence early with unparalleled sensitivity. Founded in 2016 from research in Lund, their groundbreaking test is now available in the U.S. From Lab to Life: The Research Behind SAGA's BreakthroughThe

https://www.innovation.lu.se/en/article/transforming-cancer-care-saga-diagnostics-test-now-launched-us - 2025-07-09

Published 23 June 2025 LU Ventures portfolio company Xenergic, a spin-off from Lund University, has reached a pivotal commercial milestone. Its revolutionary low-power memory technology is now in mass production with a component manufacturer. In modern mobile phones, smartwatches, and other connected devices, the on-chip memory can be responsible for more than 50% of the total energy consumption.

https://www.innovation.lu.se/en/article/breakthrough-xenergic-energy-saving-memory-enters-mass-production - 2025-07-09

By lina [dot] tornquist [at] innovation [dot] lu [dot] se (Lina Törnquist) - published 26 June 2025 Can innovation strengthen research? Heiner Linke, professor of nanophysics and member of the Royal Swedish Academy of Sciences, has done exactly that by combining research and innovation. His own attitude towards utilisation and innovation has evolved from a sense of duty to passion: "Now I think it

https://www.innovation.lu.se/en/article/you-get-best-both-worlds-heiner-linke-why-swedish-researchers-should-invest-innovation - 2025-07-09